Nanomedicine, an interdisciplinary field at the intersection of nanotechnology and medical sciences, has emerged as a revolutionary approach to diagnosing, treating, and preventing diseases at the molecular and cellular levels. By utilizing nanoscale materials and engineered nanoparticles, nanomedicine offers enhanced drug delivery mechanisms, improved imaging techniques, and innovative therapeutic interventions with increased precision and reduced systemic toxicity. The application of nanotechnology in medicine has led to significant advancements in oncology, neurology, regenerative medicine, and infectious disease treatment [1].
The development of nanomedicine is driven by the need for more effective and minimally invasive medical treatments, addressing the limitations of conventional therapies. Nanoparticles, nanorobots, and nanocarriers enable targeted drug delivery, crossing biological barriers such as the blood-brain barrier and tumor microenvironments, thereby enhancing therapeutic efficacy. Moreover, the integration of artificial intelligence and nanotechnology is shaping the future of personalized medicine, paving the way for tailored treatment strategies [2-4].
This paper explores the evolution of nanomedicine, key technological advancements, clinical applications, challenges, and future prospects, highlighting its transformative potential in modern healthcare.
1. Key Technologies in Nanomedicine
Nanoparticles for Drug Delivery [2, 6]
Liposomes: Spherical vesicles with lipid bilayers that enhance drug solubility.
Polymeric Nanoparticles: Biodegradable carriers made from polymers like PLGA for controlled drug release.
Metallic Nanoparticles: Gold, silver, and iron oxide nanoparticles for imaging, cancer therapy, and antibacterial applications.
Lipid Nanoparticles (LNPs): Used in mRNA vaccines and gene therapy for targeted delivery.
Nanobiosensors and Imaging [1,7]
Quantum Dots (QDs): Fluorescent semiconductor particles used for biomolecular imaging.
Magnetic Nanoparticles: Iron oxide nanoparticles used as MRI contrast agents.
Carbon Nanotubes: Used for biosensing, imaging, and drug delivery.
Nanorobotics and Smart Drug Delivery [8,9]
Nanorobots: Tiny machines programmed for targeted therapy and diagnostics.
Stimuli-Responsive Nanoparticles: Drug carriers that release medication in response to specific triggers (e.g., acidic tumor environments).
Gene Therapy and Nanomedicine [10-12]
mRNA Delivery: Lipid nanoparticles were used to deliver mRNA COVID-19 vaccines.
CRISPR-Cas9 with Nanoparticles: Enables precise gene editing for genetic disorders.
2. Applications of Nanomedicine
A
B
C
Figure 2. Applications of Nanomedicine. A. Statistics of nanomedicines marketed and in different stages of clinical trials. B. Indications of nanomedicines on the market or in clinical trials. C. The percent (%) of nanomedicine types on the market or in clinical trials. Reproduced with permission from Ref. [5]
Cancer treatment [3,4]
- Targeted Chemotherapy: Nanoparticles allow precise delivery of chemotherapy drugs to cancer cells, reducing side effects.
- Photothermal Therapy: Gold nanoparticles convert light into heat to destroy cancer cells.
- Gene Silencing: siRNA-loaded nanoparticles can suppress oncogenes in tumors.
Neurological Disorders [13,14]
- Blood-Brain Barrier (BBB) Penetration: Nanoparticles can cross the BBB to deliver drugs for Alzheimer’s and Parkinson’s disease.
- Neuroprotective Nanoparticles: Reduce inflammation and oxidative stress in neurodegenerative diseases.
Infectious Disease Treatment [15,16]
- Nanovaccines: Used in COVID-19 vaccines and under development for HIV, malaria, and tuberculosis.
- Antimicrobial Nanoparticles: Silver and copper nanoparticles have antibacterial and antiviral properties.
Regenerative Medicine [17,18]
- Nanostructured Scaffolds: Used in tissue engineering for wound healing, bone regeneration, and organ repair.
- Stem Cell Delivery: Nanocarriers enhance the efficiency of stem cell therapies.
References
1. Wang, B., et al., Current advance of nanotechnology in diagnosis and treatment for malignant tumors. Signal Transduct Target Ther, 2024. 9(1): p. 200.
2. Halwani, A.A., Development of Pharmaceutical Nanomedicines: From the Bench to the Market. Pharmaceutics, 2022. 14(1).
3. Lammers, T., Nanomedicine Tumor Targeting. Adv Mater, 2024. 36(26): p. e2312169.
4. Tian, J., et al., Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications. Int J Nanomedicine, 2023. 18: p. 7923-7940.
5. Liu, Q., et al., Current research trends of nanomedicines. Acta Pharmaceutica Sinica B, 2023. 13(11): p. 4391-4416.
6. Jash, A., A. Ubeyitogullari, and S.S.H. Rizvi, Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances. J Mater Chem B, 2021. 9(24): p. 4773-4792.
7. Mostafa, I.M., et al., Recent Applications and Future Perspectives of Chemiluminescent and Bioluminescent Imaging Technologies. Chem Biomed Imaging, 2023. 1(4): p. 297-314.
8. Kong, X., et al., Advances of medical nanorobots for future cancer treatments. J Hematol Oncol, 2023. 16(1): p. 74.
9. Wang, S., et al., Living material-derived intelligent micro/nanorobots. Biomater Sci, 2025. 13(6): p. 1379-1397.
10. Tenchov, R., et al., Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. ACS Nano, 2021. 15(11): p. 16982-17015.
11. Liu, F., et al., Cryo-shocked tumor cells deliver CRISPR-Cas9 for lung cancer regression by synthetic lethality. Sci Adv, 2024. 10(13): p. eadk8264.
12. Ma, L., et al., Mulberry Leaf Lipid Nanoparticles: a Naturally Targeted CRISPR/Cas9 Oral Delivery Platform for Alleviation of Colon Diseases. Small, 2024. 20(25): p. e2307247.
13. Nimgampalle, M., et al., Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications. Ageing Res Rev, 2023. 89: p. 101994.
14. Li, J., et al., Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders. Oxid Med Cell Longev, 2022. 2022: p. 3999083.
15. Gao, X., et al., Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases. ACS Nano, 2023. 17(24): p. 24514-24538.
16. Yu, R., et al., Engineering Antimicrobial Metal-Phenolic Network Nanoparticles with High Biocompatibility for Wound Healing. Adv Mater, 2024. 36(6): p. e2307680.
17. Moghassemi, S., et al., Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade. Bioact Mater, 2024. 36: p. 126-156.
18. Lotfy, A., N.M. AboQuella, and H. Wang, Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther, 2023. 14(1): p. 66.